nach oben

Journal of Neurology

Erschienen in:

28.04.2016 | Original Communication

Deep brain stimulation improves gait velocity in Parkinson’s disease: a systematic review and meta-analysis

verfasst von: Jaimie A. Roper, Nyeonju Kang, Juliana Ben, James H. Cauraugh, Michael S. Okun, Chris J. Hass

Erschienen in: Journal of Neurology | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

In Parkinson’s disease (PD), slow gait speed is significantly related to clinical ratings of disease severity, impaired performance of daily activities, as well as increased overall disability. Conducting a meta-analysis on gait speed is an objective and quantitative technique to summarize the effectiveness of DBS and to determine the effect sizes for future studies. We conducted a systematic review and meta-analysis that analyzed the effects of deep brain stimulation (DBS) surgery on gait speed in patients with PD to gain fundamental insight into the nature of therapeutic effectiveness. A random effects model meta-analysis on 27 studies revealed a significant overall standardized mean difference medium effect size equal to 0.60 (SE = 0.06; p < 0.0001; Z = 10.58). Based on our synthesis of the 27 studies, we determined the following: (1) a significant and medium effect size indicating DBS improves gait speed; (2) DBS improved gait speed regardless of whether the patients were tested in the on or off medication state; (3) both bilateral and unilateral DBS led to gait speed improvement; (4) the effects of DBS on gait speed in the data collection sessions after surgery (DBS on vs. off) were comparable with data collection before surgery (before surgery vs. DBS after surgery); and (5) when evaluating the effects of DBS and medication on gait speed suprathreshold doses were comparable to normal dosages of medication and DBS. The current analysis provides objective evidence that both unilateral and bilateral DBS provide a therapeutic benefit on gait speed in persons with PD.

Hass CJ, Malczak P, Nocera J, Stegemöller EL, Wagle Shukla A, Malaty I, Jacobson IV CE, Okun MS, McFarland N (2012) Quantitative normative gait data in a large cohort of ambulatory persons with Parkinson’s disease. PLoS One. doi:10.1371/journal.pone.0042337

Plummer-D’Amato P, Altmann LJ, Reilly K (2011) Dual-task effects of spontaneous speech and executive function on gait in aging: exaggerated effects in slow walkers. Gait Posture. doi:10.1016/j.gaitpost.2010.11.011

Hollman JH, McDade EM, Petersen RC (2011) Normative spatiotemporal gait parameters in older adults. Gait Posture. doi:10.1016/j.gaitpost.2011.03.024 PubMedPubMedCentral

Brusse KJ, Zimdars S, Zalewski KR, Steffen TM (2005) Testing functional performance in people with Parkinson disease. Phys Ther 85:134–141PubMed

Himann JE, Cunningham DA, Rechnitzer PA, Paterson DH (1988) Age-related changes in speed of walking. Med Sci Sports Exerc 20:161–166CrossRefPubMed

White DK, Neogi T, Nevitt MC, Peloquin CE, Zhu Y, Boudreau RM, Cauley JA, Ferrucci L, Harris TB, Satterfield SM, Simonsick EM, Strotmeyer ES, Zhang Y (2013) Trajectories of gait speed predict mortality in well-functioning older adults: the Health Aging and Body Composition study. J Gerontol A Biol Sci Med Sci. doi:10.1093/gerona/gls197

Lim LI, van Wegen EE, de Goede CJ, Jones D, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Kwakkel G (2005) Measuring gait and gait-related activities in Parkinson’s patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord 11:19–24CrossRefPubMed

Morris ME, Matyas TA, Iansek R, Summers JJ (1996) Temporal stability of gait in Parkinson’s disease. Phys Ther 76:763–777PubMed

Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E, Fox M, Guralnik JM (2003) Physical performance measures in the clinical setting. J Am Geriatr Soc 51:314–322CrossRefPubMed

10.

Elbers RG, van Wegen EE, Verhoef J, Kwakkel G (2013) Is gait speed a valid measure to predict community ambulation in patients with Parkinson’s disease? J Rehabil Med. doi:10.2340/16501977-1123 PubMed

11.

Ellis TD, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Thackeray A, Thiese MS, Dibble LE (2016) Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease. Parkinsonism Relat Disord 25:65–71CrossRefPubMed

12.

Tan D, Danoudis M, McGinley J, Morris ME (2012) Relationships between motor aspects of gait impairments and activity limitations in people with Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2011.07.014

13.

Nisenzon AN, Robinson ME, Bowers D, Banou E, Malaty I, Okun MS (2011) Measurement of patient-centered outcomes in Parkinson’s disease: what do patients really want from their treatment? Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2010.09.005 PubMedPubMedCentral

14.

Borenstein M (2009) Introduction to meta-analysis. Wiley, ChichesterCrossRef

15.

Rosenthal R (1995) Writing meta-analytic reviews. Psychol Bull 118:183–192CrossRef

16.

Rosenthal R, DiMatteo MR (2001) Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol. doi:10.1146/annurev.psych.52.1.59 PubMed

17.

Rosenthal R, Hiller JB, Bornstein RF, Berry DT, Brunell-Neuleib S (2001) Meta-analytic methods, the Rorschach, and the MMPI. Psychol Assess 13:449–451CrossRefPubMed

18.

Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. doi:10.1002/jrsm.12 PubMed

19.

Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, Orlando

20.

Sutton AJ (2000) Methods for meta-analysis in medical research. Wiley, Chichester

21.

Cumming G, Fidler F, Kalinowski P, Lai J (2012) The statistical recommendations of the american psychological association publication manual: effect sizes, confidence intervals, and meta-analysis. Aust J Psychol 64:138–146. doi:10.1111/j.1742-9536.2011.00037.x CrossRef

22.

Cohen J (1988) Statistical power analysis for the behavioral sciences. L. Erlbaum Associates, Hillsdale

23.

Kelly VE, Israel SM, Samii A, Slimp JC, Goodkin R, Shumway-Cook A (2010) Assessing the effects of subthalamic nucleus stimulation on gait and mobility in people with Parkinson disease. Disabil Rehabil. doi:10.3109/09638280903374139

24.

Peppe A, Pierantozzi M, Chiavalon C, Marchetti F, Caltagirone C, Musicco M, Stanzione P, Stefani A (2010) Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson’s disease. Gait Posture. doi:10.1016/j.gaitpost.2010.07.012 PubMed

25.

Krystkowiak P, Blatt JL, Bourriez JL, Duhamel A, Perina M, Blond S, Guieu JD, Destee A, Defebvre L (2003) Effects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease. Arch Neurol 60:80–84CrossRefPubMed

26.

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ. doi:10.1136/bmj.327.7414.557

27.

Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, New JerseyCrossRef

28.

Fanelli D (2009) How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS ONE. doi:10.1371/journal.pone.0005738 PubMedPubMedCentral

29.

Sterne JA, Egger M, Smith GD (2001) Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323:101–105CrossRefPubMedPubMedCentral

30.

Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463CrossRefPubMed

31.

Rothstein H, Sutton AJ, Borenstein M (2005) Publication bias in meta-analysis: prevention, assessment and adjustments. Wiley, Hoboken, NJCrossRef

32.

Piper M, Abrams GM, Marks Jr WJ (2005) Deep brain stimulation for the treatment of Parkinson’s disease: overview and impact on gait and mobility. NeuroRehabilitation

33.

Liu W, McIntire K, Kim SH, Zhang J, Dascalos S, Lyons KE, Pahwa R (2005) Quantitative assessments of the effect of bilateral subthalamic stimulation on multiple aspects of sensorimotor function for patients with Parkinson’s disease. Parkinsonism Relat Disord 11:503–508CrossRefPubMed

34.

Faist M, Xie J, Kurz D, Berger W, Maurer C, Pollak P, Lucking CH (2001) Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson’s disease. Brain 124:1590–1600CrossRefPubMed

35.

Xie J, Krack P, Benabid AL, Pollak P (2001) Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait. J Neurol 248:1068–1072CrossRefPubMed

36.

Okun MS (2012) Deep-brain stimulation for Parkinson’s disease. N Engl J Med. doi:10.1056/NEJMct1208070 PubMed

37.

Alberts JL, Hass CJ, Vitek JL, Okun MS (2008) Are two leads always better than one: an emerging case for unilateral subthalamic deep brain stimulation in Parkinson’s disease. Exp Neurol. doi:10.1016/j.expneurol.2008.07.019 PubMedPubMedCentral

38.

Taba HA, Wu SS, Foote KD, Hass CJ, Fernandez HH, Malaty IA, Rodriguez RL, Dai Y, Zeilman PR, Jacobson CE, Okun MS (2010) A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg. doi:10.3171/2010.8.JNS10312 PubMed

39.

Okun MS, Foote KD (2010) Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother 10:1847–1857CrossRefPubMedPubMedCentral

40.

Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW (2003) Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson’s disease. Mov Disord. doi:10.1002/mds.10493

41.

Chung SJ, Jeon SR, Kim SR, Sung YH, Lee MC (2006) Bilateral effects of unilateral subthalamic nucleus deep brain stimulation in advanced Parkinson’s disease. Eur Neurol 56:127–132CrossRefPubMed

42.

Germano IM, Gracies JM, Weisz DJ, Tse W, Koller WC, Olanow CW (2004) Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J Neurosurg. doi:10.3171/jns.2004.101.1.0036 PubMed

43.

Kumar R, Lozano AM, Sime E, Halket E, Lang AE (1999) Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 53:561–566CrossRefPubMed

44.

Tabbal SD, Ushe M, Mink JW, Revilla FJ, Wernle AR, Hong M, Karimi M, Perlmutter JS (2008) Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Exp Neurol. doi:10.1016/j.expneurol.2008.01.024

45.

Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436–1438CrossRefPubMed

46.

Benabid AL, Chabardes S, Mitrofanis J, Pollak P (2009) Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease. Lancet Neurol. doi:10.1016/S1474-4422(08)70291-6

47.

Allert N, Volkmann J, Dotse S, Hefter H, Sturm V, Freund HJ (2001) Effects of bilateral pallidal or subthalamic stimulation on gait in advanced Parkinson’s disease. Mov Disord. doi:10.1002/mds.1222

48.

Goff LK, Jouve L, Melon C, Salin P (2009) Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson’s disease. Parkinsonism Relat Disord. doi:10.1016/S1353-8020(09)70807-7 PubMed

49.

Plaha P, Khan S, Gill SS (2008) Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry. (jnnp.2006.112334 [pii])

50.

Mazzone P, Paoloni M, Mangone M, Santilli V, Insola A, Fini M, Scarnati E (2014) Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson’s disease: effects on gait initiation and performance. Gait Posture. doi:10.1016/j.gaitpost.2014.05.002 PubMed

51.

*Carpinella I, Crenna P, Marzegan A, Rabuffetti M, Rizzone M, Lopiano L, Ferrarin M (2007) Effect of L-dopa and subthalamic nucleus stimulation on arm and leg swing during gait in Parkinson’s Disease. Conf Proc IEEE Eng Med Biol Soc. doi:10.1109/IEMBS.2007.4353888

52.

*Fasano A, Herzog J, Seifert E, Stolze H, Falk D, Reese R, Volkmann J, Deuschl G (2011) Modulation of gait coordination by subthalamic stimulation improves freezing of gait. Mov Disord. doi:10.1002/mds.23583

53.

*Ferrarin M, Rizzone M, Lopiano L, Recalcati M, Pedotti A (2004) Effects of subthalamic nucleus stimulation and L-dopa in trunk kinematics of patients with Parkinson’s disease. Gait Posture. doi:10.1016/S0966-6362(03)00058-4

54.

*Ferrarin M, Rizzone M, Bergamasco B, Lanotte M, Recalcati M, Pedotti A, Lopiano L (2005) Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson’s disease. Exp Brain Res. doi:10.1007/s00221-004-2036-5

55.

*Ferrarin M, Carpinella I, Rabuffetti M, Rizzone M, Lopiano L, Crenna P (2007) Unilateral and bilateral subthalamic nucleus stimulation in Parkinson’s disease: effects on EMG signals of lower limb muscles during walking. IEEE Trans Neural Syst Rehabil Eng. doi:10.1109/TNSRE.2007.897000

56.

*Hausdorff JM, Gruendlinger L, Scollins L, O’Herron S, Tarsy D (2009) Deep brain stimulation effects on gait variability in Parkinson’s disease. Mov Disord. doi:10.1002/mds.22554

57.

*Hill KK, Campbell MC, McNeely ME, Karimi M, Ushe M, Tabbal SD, Hershey T, Flores HP, Hartlein JM, Lugar HM, Revilla FJ, Videen TO, Earhart GM, Perlmutter JS (2013) Cerebral blood flow responses to dorsal and ventral STN DBS correlate with gait and balance responses in Parkinson’s disease. Exp Neurol. doi:10.1016/j.expneurol.2012.12.003

58.

* Iansek R, Rosenfeld JV, Huxham FE (2002) Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease. Med J Aust. (ian10553_fm [pii])

59.

*Johnsen EL, Mogensen PH, Sunde NA, Ostergaard K (2009) Improved asymmetry of gait in Parkinson’s disease with DBS: gait and postural instability in Parkinson’s disease treated with bilateral deep brain stimulation in the subthalamic nucleus. Mov Disord. doi:10.1002/mds.22419

60.

*Johnsen EL, Sunde N, Mogensen PH, Ostergaard K (2010) MRI verified STN stimulation site–gait improvement and clinical outcome. Eur J Neurol. doi:10.1111/j.1468-1331.2010.02962.x

61.

*Lohnes CA, Earhart GM (2012) Effect of subthalamic deep brain stimulation on turning kinematics and related saccadic eye movements in Parkinson disease. Exp Neurol. doi:10.1016/j.expneurol.2012.05.001

62.

*Lubik S, Fogel W, Tronnier V, Krause M, Konig J, Jost WH (2006) Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation. J Neural Transm. doi:10.1007/s00702-005-0310-8

63.

*McNeely ME, Hershey T, Campbell MC, Tabbal SD, Karimi M, Hartlein JM, Lugar HM, Revilla FJ, Perlmutter JS, Earhart GM (2011) Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson’s disease. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp.2010.232900

64.

*Muniz AM, Liu H, Lyons KE, Pahwa R, Liu W, Nadal J (2010) Quantitative evaluation of the effects of subthalamic stimulation on gait in Parkinson’s disease patients using principal component analysis. Int J Neurosci. doi:10.3109/00207454.2010.504904

65.

*Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB (2012) Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg. doi:10.3171/2012.8.JNS112006

66.

*Rochester L, Chastin SF, Lord S, Baker K, Burn DJ (2012) Understanding the impact of deep brain stimulation on ambulatory activity in advanced Parkinson’s disease. J Neurol. doi:10.1007/s00415-011-6301-9

67.

*Seri-Fainshtat E, Israel Z, Weiss A, Hausdorff JM (2013) Impact of sub-thalamic nucleus deep brain stimulation on dual tasking gait in Parkinson’s disease. J Neuroeng Rehabil. doi:10.1186/1743-0003-10-38

68.

*Stolze H, Klebe S, Poepping M, Lorenz D, Herzog J, Hamel W, Schrader B, Raethjen J, Wenzelburger R, Mehdorn HM, Deuschl G, Krack P (2001) Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology

69.

Vallabhajosula S, Haq IU, Hwynn N, Oyama G, Okun M, Tillman MD, Hass CJ (2015) Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson’s disease: a quantitative study. Brain Stimul 8:64–75. doi:10.1016/j.brs.2014.10.011 CrossRefPubMed

Titel: Deep brain stimulation improves gait velocity in Parkinson’s disease: a systematic review and meta-analysis
verfasst von: Jaimie A. Roper
Nyeonju Kang
Juliana Ben
James H. Cauraugh
Michael S. Okun
Chris J. Hass
Publikationsdatum: 28.04.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 6/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8129-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2016

A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes

Feasibility of external rhythmic cueing with the Google Glass for improving gait in people with Parkinson’s disease

Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study

Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis